Connect with us

Health

Health Tech Companies Secure Over $400 Million in December Funding

Editorial

Published

on

Health technology companies experienced a robust month of funding in December 2023, collectively securing over $400 million across several significant investment rounds. These funds will enhance the capabilities and reach of companies focused on improving healthcare access and efficiency.

Curative Raises $150 Million in Series B Funding

Austin-based Curative has successfully raised $150 million in its Series B funding round. The company offers an employer-based health plan that provides members with $0 out-of-pocket costs, covering all expenses including co-pays, deductibles, and coinsurance, provided they complete an annual preventative health visit. The funding round was led by Chris Anderson, Chairman of TED, through his Upside Vision Fund, with participation from notable investors such as Justin Mateen, founder of JAM Fund, and Mike Novogratz of Galaxy Digital, among others. This financing is aimed at scaling Curative’s operations nationally.

Angle Health Secures $134 Million

San Francisco’s Angle Health has also made headlines by raising $134 million in its Series B funding. As a digital healthcare benefits provider, Angle Health utilizes AI-powered services to offer care navigation through its app. The funding round, led by Portage, attracted a diverse array of investors including Blumberg Capital, Mighty Capital, and Y Combinator. This latest round, which comprises both debt and equity, brings the total capital raised by Angle Health to approximately $200 million. The company now serves over 3,000 employers across 44 states, offering customizable health plans that include telemedicine and behavioral health services.

Paradigm Health Collects $78 Million

Paradigm Health, focused on enhancing equity in clinical trial access, has raised $78 million in its Series B funding. The company’s AI-driven platform automates the patient matching process for clinical trials, making it easier for health systems to enroll eligible patients. The funding was led by ARCH Venture Partners and included contributions from DFJ Growth, General Catalyst, and the American Cancer Society’s BrightEdge Fund. This investment will enable Paradigm Health to expand its services as demand rises from biopharmaceutical companies for more efficient trials.

Artera, a healthcare technology firm based in Santa Barbara, California, has raised $65 million to enhance its communication platform for healthcare providers. The company’s solutions utilize AI to streamline patient interactions, including appointment scheduling and billing. The funding round received support from investors such as Lead Edge Capital and Health Velocity Capital, aiming to facilitate the growth of Artera and the integration of agentic AI in healthcare communication.

The notable funding rounds in December reflect a growing interest in health technology solutions that prioritize accessibility and efficiency in the healthcare system. As these companies expand, they may significantly impact how healthcare is delivered and experienced across various markets.

Our Editorial team doesn’t just report the news—we live it. Backed by years of frontline experience, we hunt down the facts, verify them to the letter, and deliver the stories that shape our world. Fueled by integrity and a keen eye for nuance, we tackle politics, culture, and technology with incisive analysis. When the headlines change by the minute, you can count on us to cut through the noise and serve you clarity on a silver platter.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.